The PBRM1 gene, which stands for Polybromo 1, encodes a subunit of the SWI/SNF (Switch/Sucrose Non-Fermentable) chromatin remodeling complex. This complex plays a critical role in maintaining normal chromatin structure and regulating gene expression. The encoded protein contains a bromodomain, which allows it to bind acetylated histones, and a bromo-adjacent homology (BAH) domain, which is involved in DNA binding and chromatin targeting.Mutations in PBRM1 are frequently observed in several types of cancer, most notably in clear cell renal cell carcinoma (ccRCC), where it is one of the most commonly mutated genes. Loss-of-function mutations in PBRM1 have been associated with impaired chromatin remodeling, leading to aberrant gene expression and subsequent tumorigenesis. Furthermore, PBRM1 mutations have been correlated with better prognosis in ccRCC patients, indicating its potential as a predictive biomarker.